Latest news
Loading news…
Anchiano Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Jerusalem, Yerushalayim, Israel Founded 2004 11-50 employees For Profit
Anchiano is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer.
Anchiano Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Anchiano Therapeutics was acquired by Chemomab in 2021.
Total Funding
$32.42M
Funding Rounds
3
Last Funding
Acquisitions
0
Monthly Visits
Contacts
1
About Anchiano Therapeutics
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- BICL
- Exchange
- TLV - Tel Aviv Stock Exchange
- IPO date
- Aug 1, 2006
- Delisted
- Jun 18, 2019
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
Company Info
- Founded
- 2004
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 9
- HQ
- Jerusalem, Yerushalayim, Israel
- Region
- Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA)
- Exit date
- Aug 1, 2006
- Closed
- Mar 16, 2021
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 0.3
- Trend (90d)
- 0
Anchiano Therapeutics Funding Rounds
3 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–3 of 3Show
Page 1 / 1
Anchiano Therapeutics Key People
Co-Founder & Chief Scientist
1
professional contacts at Anchiano Therapeutics
Contact execs at Anchiano Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Anchiano Therapeutics
Loading news…
FAQs about Anchiano Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.